November 12, 2024

10.00 Pistoia Alliance Project Workshops 
  • FAIR
  • IDMP
  • AI COMMUNITY OF EXPERTS
  • CLINOPPS ONTOLOGY 
  • CMC ONTOLOGY

13.30

CONFERENCE REGISTRATION 

15.00

Presidents Welcome - Becky Upton, President, Pistoia Alliance 

15.15

Keynote Presentation: 

Penn Medicine Cell and Gene Therapy From Innovation to Translation to Patients:
A Collaborative Academic to Industry Model

Professor Bruce Levine, Barbara and Edward Netter Professor in Cell Gene Therapy, University of Pennsylvania 

15.45

Keynote Presentation: Regulatory perspective

Kevin Snyder, Associate Director, Non Clinical Informatics, FDA

16.15 

Elsevier Keynote Presentation

Mirit Eldor, Managing Director, Life Sciences Solutions, Elsevier

16.30

Pharma perspective 

16.45

Pistoia Alliance perspective and round up of the afternoon.

Christian Baber, Chief Portfolio Officer 

17.00 - 19.00

Close 

Welcome drinks reception and poster viewing, meet the Pistoia Alliance project managers 

 

November 13, 2024

08.30

Conference opens 

08.30

Presidents Welcome - Becky Upton, President, Pistoia Alliance 

08.45

Keynote Presentation: Harnessing AI to Expedite R&D

Simon Davies, Vice President, Data Sciences Institute, R&D, Takeda

09.15

Pistoia Alliance AI perspective 

Vladimir Makarov, Project Manager, Pistoia Alliance 

09.30

Pistoia Alliance portfolio and new ideas session 

Christian Baber, Chief Portfolio Officer 

Thierry Escudier, Portfolio Lead

09.55

IVP Future project 

Larry Callahan, FDA 

Chris Butler, Senior Principal Data Scientist, AbbVie 

10.10

Partners in R&D Innovation

Elsevier 

10.25

Partners in R&D Innovation 

Amino Data 

10.40

Morning Coffee 

11.10

Partners in R&D Innovation 

Rancho BioSciences  

11.40

Keynote Presentation 

Santha Ramakrishnan, VP, Head of R&D Data Strategy and Governance, Bayer, 

12.10

Pistoia Alliance View Point on Data 

Giovanni Nisato, Project Manager, Pistoia Alliance 

12.25

ZS Associates white paper presentation "The Data Fusion R(evolution): Transforming R&D Outcomes with Integrated Data” followed by panel discussion 

Bruce Press, Principle ZS Associates

Adam Schneider, Director of Strategy & Operations 

12.45 - 14.00

Lunch and Poster Viewing  

 

BREAKOUT SESSIONS 14.00 - 15.30

 

BREAKOUT ONE 

Semantic Management of Data 

A session focused on the importance of organization and governance of data & metadata to future-proof our data and allow the impact of the FAIR principles to be recognized.

14.00 Introduction to the session 

14.15 Business Value Drivers of FAIR 
Genta Spahiu, Data Governance Lead, Pfizer 

14.30 Sponsored talk - Standards in Semantics 

14:45 Connect FAIR maturity matrix to business value 
John Apathy, Chief Solutions Officer, Life Sciences Industry Lead, XponentL

15.00 Panel discussion 

15.30 Close 

 

BREAKOUT TWO 

Applications of Data 

Data is an asset that only has value when used. This session focuses on the application of data to drive decisions whether through simple analytics or more complex approaches such as AI/ML

14.00 Introduction to the session 

14.15 Application of AI in drug discovery

Abhishek Pandey, Group Lead, Pharma Discovery, AbbVie 

14:30 Applications of AI in Clinical Development

Prateek Kacker, Director - Data Science and AI, Novartis

14.45 Talk tbc 

15.00 Regulatory Applications of AI 

Karin Schneider, Associate Director, Johnson & Johnson Innovative Medicines 

15.15 Panel discussion

15.30 Close 

 

BREAKOUT THREE 

Sustainability Driven R&D

A session focuses on the sustainability best practices across the R&D value chain, from new approaches in toxicology to evaluating impact of clinical trials design on carbon footprint. 

 

14.00 Introduction to the session 

14.15 How non animal models can contribute to your R&D sustainability objectives 

Alastair King, Head of Biology, Eurofins

14.30 Speaker tbc 

14:45 How GSK is driving sustainability in R&D 

Steve Vitale, Green Lab Program Manager, GSK 

15.00 Panel discussion 

15.30 Close 

15.30

Afternoon Coffee 

16.00

CSCS Community’s response to DEA’s Proposed Disposal Regulations and its Impact on Industry

Jessie Bin Song, Merck

16.15

Sponsor talk tbc 

16.30

Closing Keynote Address

Science Philanthropy Spotlight on AI and Patient-Driven Research

  • Overview of the Chan Zuckerberg Initiatives science philanthropy model 
  • Successes and challenges of patient-driven research in rare disease
  • Future of AI and biology 

17.00

19.00 
Close 

Closing Remarks, Drinks and entertainment 🎸🎹🎤